The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
There were rumours, and some dot joining went on, but the confirmation only came the day of suspension. Until that time we were all gambling on an RTO into something being the outcome - that's why I held and presume it's why others did.
And for the record, everything that JM has posted on this makes perfect sense and seems based on facts and numbers; the wildly optimistic valuations on re-list seem to be backed by nothing other then wishful thinking.
Nothing to do with us - Iconic is reversing into ITS Holdings 2023 Ltd.
Yes not looking too good right now, but as Goldfinger states below, ITS can request an extension. I seem to remember this happening to the predecessor of CIZ, which was suspended for 18months ish prior to RTO (and to be honest, should've stayed that way, it's been a disaster for investors)
I highly doubt that's the issue Jimmy, there's far more complicated accounting issues that are solved on a daily basis. If they wanted to file the accounts it would be easy enough to get an auditor to prepare and file.
Your second para contradicts the first; it's not over until it's over, which is the end of the day.
Postpone the misery until the end of the day …
Doesn't make much sense that Jimmy; there's some huge companies on AIM (JET, ASOS etc) and some absolute dogs with main market listings.. SYME anyone?
the scenario is as follows. flip a coin - RNS tomorrow about an RTO or delisting. that's it
I said he's lost nothing, which as of today he has not. Whether or not his holding is worth anything in 24 hours is another question.
Agreed re Frisby; he's lost nothing.
still quietly confident here, but let's see
It’s not complicated at all, you’re joining non-existent (and irrelevant) dots. ITS either goes pop on Wednesday or it enters into an RtO transaction. That’s it.
I agree with your first sentence. Your second makes no sense to me. What are you saying? There's no mystery surrounding the Sept share issue, it's all in the RNS:
"Itsarm plc (the "Company") is pleased to announce the appointment of Zeus Capital Limited as its Nominated Adviser and Sole Broker, with immediate effect.
The Company also announces the issue of 1,630,612 ordinary shares of 0.25p each in the Company ("Ordinary Shares") in lieu of payment of certain creditors to conserve cash within the business."
Bodycare is just the trading name of GR & MM Blackledge PLC. Which in turn is owned by JDS50 Ltd, a Jas Singh company. Jas Singh is the man behind Baaj Capital LLP.
Latest available accounts for Blackledge are 2022 - turnover of ca 200 million, and a small loss in that year. I would imagine 2023 saw increased turnover and profit.